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Abstract 
Non-steroidal ntiestrogens such as tamoxifen are known to exert cytotoxic effects against various cell lines in culture. When the 
antiestrogens are present at sufficiently high concentrations, their cytotoxicity cannot be reversed by estrogens and is demonstrable even 
with cell lines which lack the estrogen receptor. The mechanism of this cytotoxicity, which is clearly independent ofestrogen antagonism, 
remains unknown. Using two murine cancer cell lines (the K36 leukemia nd the EL4 lymphoma cell line), the human breast cancer cell 
line MCF7, and two non-steroidal antiestrogens (tamoxifen and clomiphene), our laboratory attempted to determine whether the cytotoxic 
action of non-steroidal antiestrogens was mediated by a mechanism requiring protein or RNA synthesis. In the case of K36 and EL4 cells, 
inclusion of tamoxifen or clomiphene in the culture medium regularly caused the viable call count to fall below 20-30% of control in 
36-48 h. Under these conditions, the addition of inhibitors of protein or RNA synthesis consistently increased viable cell count in a 
dose-dependent manner. With cultures of K36 cells grown in the presence of 10/zM tamoxifen, for example, the addition of appropriate 
concentrations of emetine, cycloheximide, puromycin, or actinomycin D increased the percentage of viable cells to 5.0, 2.4, 4.0, and 4.0 
times that of control, respectively. Additional experiments revealed that the macromolecular synthesis inhibitors, while effective in 
inhibiting protein or RNA synthesis to varying degrees, did not affect he cellular uptake of [3H]tamoxifen, suggesting that their ability to 
protect cells against antiestrogen-induced ll death was not due to an inhibition of cellular uptake of antiestrogens. In the case of MCF7 
cells, however, inhibition of protein synthesis did not protect he cells against he cytotoxic effect of tamoxifen. These observations 
suggest that non-steroidal antiestrogens may exert heir cytotoxic effect by at least two different mechanisms; only one of these require de 
novo protein synthesis. The effect of antiestrogens on K36 and EL4 cells may provide a useful system for the identification of proteins 
involved in cell death. 
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1. Introduction 
It is well recognized 1:hat non-steroidal antiestrogens 
such as tamoxifen and clomiphene are known to exert 
antiproliferative and cytotoxic effects against breast cancer 
cell lines in culture (reviewed in Ref. [1]). For cells 
containing estrogen recepl:ors, the antiproliferative ffect 
can be accounted for, at least partly, by antagonism against 
the effect of estrogens ince the effect can be reversed by 
excess estrogen if the antiestrogens are present at moderate 
concentrations [2]. When the antiestrogens are present at 
Abbreviations: AEBS, antiestrogen binding site; MTr, tetrazolium 
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sufficiently high concentrations, however, their cytotoxic 
effects cannot be reversed by estrogens [3] and are demon- 
strable even in the absence of estrogens [4] or with cell 
lines which lack the estrogen receptor [5]. The mechanism 
of this estrogen receptor-independent a iproliferative and 
cytotoxic effect of non-steroidal ntiestrogens is not under- 
stood. 
In the studies reported here, we examined the possibil- 
ity that the cytotoxic effect of non-steroidal antiestrogens 
in estrogen-receptor-negative cells is mediated by a mecha- 
nism requiring protein or RNA synthesis. Using two murine 
lymphoma cell lines (K36 and EL4) and two non-steroidal 
antiestrogens (tamoxifen and clomiphene), we demon- 
strated that inhibitors of protein and RNA synthesis can 
block the cytotoxic effect of the antiestrogens, thus sug- 
gesting that the cytotoxic action of these compounds may 
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be mediated by mechanisms requiring de novo protein or 
RNA synthesis. With the breast cancer cell line MCF7, 
however, this phenomenon was not observed. A portion of 
this work was presented in abstract form at the 1994 
Annual Meeting of the Endocrine Society at Anaheim, 
USA. 
2. Experimental procedures 
2.1. Materials 
[5,6-3H]Uridine (spec. act. 35 Ci or 1.3 TBq/mmol) 
and [N-methyl-3H]tamoxifen (spec. act. 82 Ci or 3.03 
TBq/mmol) were obtained from Amersham International 
(Buckinghamshire, UK). L-[35S]Methionine (spec. act. > 
1000 Ci or 37.0 TBq/mmol) was obtained from New 
England Nuclear (Du Pont, Wilmington, Delaware, USA). 
Cycloheximide, puromycin, emetine, tamoxifen citrate, and 
clomiphene were obtained from Sigma (St. Louis, MO, 
USA). Actinomycin D was from Fluka (Switzerland). 
Newborn calf serum was purchased from Waitaki (New 
Zealand) while cell culture media, diethylstilbestrol and 
steroids were obtained from Sigma. Other chemicals were 
of analytical grade and were obtained from conventional 
sources. 
2.2. Cell cultures 
The mouse lymphoma cell line EL4, and the AKR 
T-cell leukemia line K36 were generously provided by Dr. 
K.M. Hui (Institute of Molecular and Cellular Biology, 
National University of Singapore). MCF7 cells were ob- 
tained from the American Type Culture Collection (Rock- 
ville, MD, USA). The cells were propagated in RPMI-1640 
medium supplemented with 5% (v /v)  charcoal-stripped 
[6], lipoprotein-deficient ewborn calf serum which was 
prepared, with minor modifications, as described by Kirsten 
and Watson [7]. Briefly, after charcoal stripping [6], anhy- 
drous potassium bromide was added to the newborn calf 
serum to a concentration of 32% (w/v). After centrifuga- 
tion at 258 000 × g at 15 ° C for 24 h, the lower (lipopro- 
tein-depleted) fraction was removed by aspiration and 
extensively dialysed against 6 changes of 100 volumes of 
0.15 M sodium chloride solution over 72 h at 4 ° C. After 
sterilization by filtration through a 0.2 /xm membrane, the 
lipoprotein-deficient serum was added to the culture 
medium in an amount adjusted to be equivalent to supple- 
mentation by 5% (v/v)  of the original newborn calf 
serum. Running stock cultures were propagated in 75-cm 2
flasks (Costar, USA) at 37 ° C in an atmosphere of 5% CO 2 
in humidified air. Subcultures were carried out when cell 
densities reached 2.5-3.5 • 10  6 cells/ml for K36 and EL4 
cells. For MCF7 cells, media change was carried out every 
2-3 days; otherwise culture conditions were similar to that 
of K36 and EL4 cells. 
2.3. Cytotoxicity assays 
EL4 or K36 cells in the logarithmic phase of growth 
were harvested and plated on to 24-well plates (Costar, 
USA) at an initial cell density of 0.8-1.2 • l0  6 cells/ml. 
Cell viability of stock was routinely determined by Trypan 
blue exclusion and only cultures with viabilities > 90% 
were used. In preliminary assays, varying concentrations 
of tamoxifen and clomiphene were added to determine the 
optimal cytotoxic concentrations to use for subsequent 
studies. These compounds were initially dissolved in 
ethanol and the ethanolic solutions were added directly to 
the culture medium. The final ethanol concentration was 
usually 0.1-0.2% and never exceeded 0.5%. Control wells 
received only ethanol. In assays designed to test the effects 
of cycloheximide, puromycin, emetine, or actinomycin D, 
these inhibitors were first dissolved in either ethanol 
(cycloheximide, emetine and actinomycin D) or 
phosphate-buffered saline or RPM1-1640 (puromycin) and 
then added to the culture medium at varying concentra- 
tions. At specified times after plating, aliquots of cell 
suspensions were removed for cell counting using an 
improved Nebauer hemocytometer while cell viabilities 
were simultaneously determined by means of Trypan blue 
exclusion. The viable cell count was calculated by multi- 
plying the total cell count by the percent of cells which 
were viable. In some experiments, the viable cell count 
was quantitated by the MTT assay which depends on the 
conversion of 3(4,5-dimethylthiazol-2-yl)2,5-diphenyl-te- 
trazolium bromide to colored formazan [8]. In the case of 
MCF7 cells, 10000-15000 cells per well were plated on 
to 96-well plates. After overnight attachment, fresh medium 
containing varying concentrations of antiestrogens and in- 
hibitors were added. After one medium change on day 3, 
the assay was terminated on day 5. Viable cell count was 
determined by the MTT method [8]. 
2.4. Other procedures 
For statistical analysis, unpaired Student's t-test or 
Bonferroni's multiple comparison test [9] was employed. 
Other procedures were carried out as described in the 
appropriate figure and table legends. 
3. Results 
Preliminary studies were carried out to determine the 
concentrations of tamoxifen and clomiphene required to 
reduce cell viability to less than 30% of control (usually in 
36-48 h for K36 and EL4 cells and in 120 h for MCF7 
cells). It was found that 5-10 /xM of tamoxifen and 0.5 
~M of clomiphene would be adequate. These culture 
conditions were used in all subsequent cytotoxicity studies, 
except where indicated otherwise, to examine the effect of 
protein or RNA synthesis inhibitors. 
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Fig. 1. Effect of emetine on the cytotoxic effect of tamoxifen on K36 
cells. K36 cells were cultured with varying concentrations of emetine in 
the absence (O) or presence (O) of I0 /xM tamoxifen. After 48 h, 
aliquots of the cultures were taken for cell count and viability determina- 
tion using the Trypan blue exclusion technique. Viable cell count was 
calculated by multiplying the total cell count by the percent of total cells 
which excluded Trypan blue (percent viability). The data were representa- 
tive of three separate experiments. 
Parenthetically, we also noted that diethylstilbesterol, 
estradiol, cortisol, progesterone, and testosterone, when 
added to cell cultures at concentrations up to 10 /xM had 
no discernible ffect on cell viability. 
Fig. 1 shows the effect of the protein synthesis inhibitor 
emetine on cell viability (as measured by Trypan blue 
exclusion) of K36 cells after 48 h of culture in the 
presence or absence of 113 ~M tamoxifen. In the absence 
of tamoxifen, emetine itse]f had little effect on percent cell 
viability at concentrations up to 800 nM (upper panel). In 
the presence of tamoxifen, however, percent cell viability 
was clearly affected by emetine in a dose-dependent man- 
ner, increasing from 27% in the absence of emetine to a 
maximum of 80% in the presence of 100 nM emetine. 
Higher concentrations of emetine reduced cell viability, 
probably because of a direct cytotoxic effect of emetine 
itself. The lower panel of ]Jig. 1 depicts the total viable cell 
counts observed in the same experiment. It is clear that 
emetine, at concentration,; between 25 and 400 nM, pro- 
tects K36 cells against he cytotoxic effects of tamoxifen. 
Similar results were obtained when the MTT method [8] 
was used to quantitate viable cell count (not shown). 
Fig. 2 shows the effect of emetine on K36 cell viability 
in the presence of tamoxifen as a function of time. In the 
presence of 10 /~M tamoxifen alone, there was a rapid 
decline in percent cell viability, falling from 97% to 14% 
and 0% at 48 and 72 h respectively (upper panel). The 
addition of 0.1 /~M emetine to the incubation medium 
markedly improved cell viability so that at 48 and 72 h the 
percent viabilities remained at 94% and 84%, respectively. 
The lower panel of Fig. 2 depicts the total viable cell 
counts observed as a function of time in the same experi- 
ment. The increased cell viability, whether expressed as 
percent viability or as total viable cell count, were highly 
significant at both 48 h and 72 h (P  < 0.001). 
Similar studies were carded out with two other protein 
synthesis inhibitors, cycloheximide and puromycin, and 
with the RNA synthesis inhibitor actinomycin D. The 
results of representative experiments with these inhibitors 
are shown in Fig. 3. In all instances, under conditions 
where the presence of 10 /xM tamoxifen reduced viable 
cell count to 20% or less of control, the presence of 
cycloheximide, puromycin, or actinomycin D clearly in- 
creased viable cell count in a dose-dependent manner. 
Cycloheximide, puromycin, and actinomycin D showed 
maximum protective ffects at concentrations of 0.25 p,M, 
3.12 /xM, and 6.25 nM, respectively. Fig. 3 also shows the 
effect on viable cell count of cycloheximide, puromycin, 
or actinomycin alone. As in the case of emetine, all these 
agents are cytotoxic by themselves at higher concentra- 
tions. However, for all these macromolecular synthesis 
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Fig. 2. Time course of changes in percent cell viability and total viable 
cell count in K36 cell cultures in the presence of tamoxifen with and 
without emetine. Cell cultures were set up as described in Section 2. 
Control wells ([]) contained 0.2% ethanol. Other wells contained either 
10 /zM tamoxifen alone (O), or 10/xM tamoxifen plus 0.1 ~M emetine 
(Q). Viable cell counts were determined at 24, 48, and 72 h. Each point 
represents the mean + S.D. of triplicate determinations. 
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Fig. 3. Effect of cycloheximide, puromycin, and actinomycin D on the cytotoxic effect of tamoxifen on K36 cells. Cultures were incubated with varying 
concentrations of cycloheximide, puromycin, or actinomycin D in the absence (O) or presence (0 )  of 10 /zM tamoxifen. Total cell count and percent 
viability were determined after 48 h. The data were representative of three separate xperiments. 
inhibitors, there exists a 'window' in which the inhibitor 
exerted a protective action without being cytotoxic. 
Fig. 4 summarizes the effect of 0.1 /zM emetine, 0.25 
/xM cycloheximide, 1.56 /zM puromycin, and 2.4 nM 
actinomycin D on K36 cell viability after 42-48 h of 
culture in the presence of 10 /zM tamoxifen. All four 
compounds ignificantly and, in some instances, dramati- 
cally increased the percent cell viability (upper panel) as 
well as the total viable cell count (lower panel). Among 
the four inhibitors, emetine appeared to be most effica- 
cious in protecting the K36 cells against the cytotoxic 
action of tamoxifen, increasing percent cell viability from 
19% to 95% and viable cell count from 0.12 to 1.13 
million per well. These changes were highly significant 
(P  < 0.001) as were the changes observed with all the 
other macromolecular synthesis inhibitors (P  < 0.05 in all 
instances). The percent viabilities observed with the addi- 
tion of cycloheximide, puromycin and actinomycin D were 
2.4, 4.0, and 4.0 times that of control, while the viable cell 
counts were 4.2, 4.8, and 4.5 times that of control, respec- 
tively. 
In addition to tamoxifen, another non-steroidal antie- 
strogen, clomiphene, was also studied in experiments simi- 
lar to those performed for tamoxifen. The results, shown in 
Table 1, were similar to those obtained with tamoxifen. 
Emetine, cycloheximide, puromycin and actinomycin D, at 
the concentrations indicated, increased the percent viability 
to 4.2, 3.7, 2.4, and 2.9 times that of control, and increased 
the viable cell count to 5.3, 5.1, 2.8, and 3.4 times that of 
control, respectively. All the increases were highly signifi- 
cant (P  < 0.001). 
To determine whether the observations with K36 cells 
also apply to other cell lines, we carded out similar studies 
with the murine lymphoma cell line ELA and the breast 
cancer cell line MCF7. Table 2 shows the effect of the four 
inhibitors on the cytotoxic effect of tamoxifen against EL4 
cells. All four metabolic inhibitors significantly increased 
cell viability in the presence of 5 or 10 /xM tamoxifen. It
would appear that the ability of protein and RNA synthesis 
inhibitors to protect cells against he cytotoxic effects of 
antiestrogens applies also to EL4 cells and may represent a 
general phenomenon not restricted to one particular cell 
type. However, with MCF7 cells, we failed to observe any 
protection with the protein synthesis inhibitor emetine over 
a wide range of concentrations (Fig. 5). Emetine itself, at 
concentrations above 25 nM, was cytotoxic to MCF7 cells. 
Table 1 
Effect of macromolecular synthesis inhibitors on clomiphene-induced cytotoxicity in K36 cells 
Inhibitor Conc. Viable cell p a Viability (%) p a 
(/xM) count/well 
Control - 0.21 + 0.01 - 21.3 5- 1.5 - 
Emetine 0.1 1.06 5- 0.10 < 0.001 90.0 + 1.0 < 0.001 
Cycloheximide 0.25 1.03 5- 0.07 < 0.001 78.1 5- 1.2 < 0.001 
Puromycin 1.56 0.56 + 0.05 < 0.001 52.0 5- 2.0 < 0.001 
Actinomycin D 1.25 x 10 -3 0.68 -t- 0.09 < 0.001 62.3 5- 4.1 < 0.001 
K36 cell cultures were set up as described in the experimental procedures in the absence or presence of emetine (0.1 /zM), cycloheximide (0.25 /zM), 
puromycin (1.56 /zM), or actinomycin D (1.25 nM). All cultures contained 0.5 /xM clomiphene. After 42 h, viable cell count and percent cell viability 
were determined by Trypan blue exclusion. The values represent the mean -I- S.D. of triplicate determinations. 
a P-values were obtained by comparing the observed ata with control (no inhibitor added) using the Bonferroni multiple comparison test. 
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Fig. 4. Effect of protein or RNA synthesis inhibitors on the viability of 
K36 cells cultured in the presence of tamoxifen. Cell cultures were set up 
as described in Section 2. All cultures contained 10 txM tamoxifen with 
(+)  or without ( - )  emetine (0.1 ~M), cycloheximide (0.25 IxM), 
puromycin (1.56 txM), or actinomycin D (2.4 nM). Percent cell viability 
and total viable cell count were determined by Trypan blue exclusion 
after 42-48 h. The data represem ean 5: S.D. of quadruplicate determi- 
nations. The observed increases in percent cell viability (upper panel) or 
total viable cell count per well (lower panel) in the presence of inhibitor 
were statistically significant in al]i cases (P  < 0.05). 
The marked difference observed between the effect of 
emetine on K36 cells on the one hand (Fig. 1), and MCF7 
cells on the other hand (Fig. 5), suggests that antiestrogens 
kill cells by two or more mechanisms, not all of which are 
dependent on protein synthesis. 
We next examined the: extent to which inhibition of 
protein and RNA synthesis in intact K36 cells was inhib- 
ited by the metabolic inhibitors at concentrations which 
were cytoprotective (Fig. 6). Emetine (0.1 /~M), cyclohex- 
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Fig. 5. Effect of emetine on the cytotoxic effect of tamoxifen on MCF7 
cells. MCF7 cells were plated on to 96-well plates at an initial cell 
density of 10000-15 000 cells per well. After overnight attachment, fresh 
media containing varying concentrations of emetine and either 0 (O)  or 
10/xM (Q)  tamoxifen were added. After one change of media on day 3, 
the assay was terminated on day 5 using the MTT technique to quantitate 
viable cell count. The data represent 5:S.D. of triplicate determinations; 
where error bars are not seen, the S.D. is less than the diameter of the 
symbol. 
imide (0.25 /xM), puromycin (3.12 ~M) and actinomycin 
D (5 nM) inhibited protein or RNA synthesis by 52%, 
33%, 10%, and 55%, respectively. Higher concentrations 
of the inhibitors inhibited macromolecular synthesis to a 
greater degree, but they also tended to be cytotoxic (Figs. 
1 and 3). 
Since protection against antiestrogen-induced ll-kill- 
ing could be observed even when the inhibition of protein 
or RNA synthesis was only modest, as in the case of 
puromycin, we considered the possibility that the cytopro- 
tective effect of the metabolic inhibition might be unre- 
lated to their ability to inhibit protein or RNA synthesis. 
One possibility we examined was that these inhibitors 
could interfere with the cellular uptake of the antiestro- 
gens. Accordingly, the study shown in Table 3 was carried 
out. [3H]Tamoxifen was incubated with K36 cells in the 
Table 2 
Effect of macromolecular synthesis inhibitors on tamoxifen-induced cytotoxicity in EL4 cells 
Inhibitor Conc. Viability (%) P Viable cell count P 
(/zM) per well (X 10 -6 ) 
Emetine 0 1.5 + 0.4 < 0.01 0.05 + 0.01 < 0.05 
0.25 46.7 + 4.3 0.77 + 0.08 
Cycloheximide 0 5.0 + 0.8 < 0.01 0.06 + 0.01 < 0.05 
0.25 18.0 5:1.4 0.21 5:0.03 
Puromycin 0 0.5 5:0.1 < 0.05 0.02 5:0.01 < 0.05 
3.12 12.9 5:2.1 0.29 + 0.08 
Actinomycin D 0 0.3 5:0.4 < 0.01 0.01 + 0.01 < 0.05 
0.1 10.6 5:0.3 0.25 + 0.04 
EL4 cell cultures were set up in the absence or presence of emetine, cycloheximide, puromycin or actinomycin D. All cultures contained 5 or 10 /zM 
tamoxifen. After 42-72 h, percent cell viability and viable cell count were determined by Trypan blue exclusion. The values represent mean + S.D. The 
P-values were obtained by the unpaired Student's t-test. 
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Fig. 6. Effect of protein and RNA synthesis inhibitors on [35S]methionine 
incorporation i to protein or [3H]uridine incorporation i to RNA in intact 
K36 cells. Cell cultures containing approximately 1.0× 106 cells/ml 
were set up in 96-well plates and preincubated for 3 h at 37°C with 
varying concentrations of emetine (A), cycloheximide (B), puromycin (C) 
or actinomycin D (D). [35S]methionine was then added to A, B, and C to 
a final concentration f 0.4/xCi /ml  while [3H]uridine was added to D to 
a final concentration of 0.2 p.Ci/ml. After a further 5 h of incubation, 
cells were trapped on scintillant-coated glass microfiber filters (Beckman, 
USA) in a multiple-sample c ll harvester (Brandel, USA) and washed in 
turn with 2 × 2 ml of phosphated-buffered saline, 10% (w/v)  trichloro- 
acetic acid and 95% (v/v)  ethanol. The filters were dried and counted in 
a Beckman scintillation counter. Results were expressed as a percentage 
of counts observed in control cultures which contained no inhibitor. Each 
point represents mean _+ S.E.M. of triplicate determinations. 
absence and presence of  the inhibitors. None of the in- 
hibitors, at the concentrations indicated, had any signifi- 
cant effect on the cellular uptake of [3H]tamoxifen. These 
inhibitors also did not significantly reduce [3H]tamoxifen 
uptake by EL4 cells (not shown). These observations make 
it unlikely that the protective ffect of the inhibitors is due 
to an ability to reduce the cellular uptake of antiestrogens. 
4. D iscuss ion  
Although it is generally known that non-steroidal ntie- 
strogens have antiproliferative and cytotoxic effects, the 
mechanism of these effects is incompletely understood. In
estrogen target tissues, at least part of this effect is be- 
lieved to be due to estrogen antagonism. However, for 
cells with no estrogen receptors, the mechanism by which 
non-steroidal ntiestrogens exert their cytotoxic action is 
obscure. 
The studies reported here demonstrate hat the cytotoxic 
effects of non-steroidal ntiestrogens are clearly blocked 
by inhibitors of protein and RNA synthesis in K36 and 
EL4 cells. Since the observations on these two cell lines 
were obtained with two different antiestrogens and four 
different macromolecular synthesis inhibitors, it is reason- 
able to infer that the cell death induced by non-steroidal 
antiestrogens in K36 and EL4 cells may require protein or 
RNA synthesis. This possibility is particularly attractive 
because the four metabolic inhibitors tudied are known to 
inhibit protein synthesis via distinct mechanisms: cyclo- 
heximide inhibits peptidyl transferase activity, puromycin 
causes premature peptide-chain termination, emetine in- 
hibits ribosomal translocation along the mRNA template, 
while actinomycin D inhibits RNA synthesis [10,11]. 
We were somewhat surprised to observe that, unlike 
K36 and EL4 cells, the antiestrogen-induced ll death of 
MCF7 cells was not blocked by emetine, a protein synthe- 
sis inhibitor (Fig. 5). The breast cancer cell line MCF7 
contains estrogen receptors; its responses to antiestrogen 
Table 3 
Uptake of [- H]tamoxifen by K36 cells 
Inhibitor used Uptake of [ 3 H]tamoxifen P 
(% of control) 
Control 100 + 10.0 - 
Cycloheximide (0.25/xM) 94.6 + 4.1 > 0.05 
Puromycin (1.5 ~M) 106.1 + 12.2 > 0.05 
Emetine (50 nM) 100.4 _+ 4.3 > 0.05 
Actinomycin D (2 nM) 106.2 + 11.3 > 0.05 
K36 cells in the absence or presence of inhib!tors of protein or RNA synthesis were incubated with 100000 cpm of [3H]tamoxifen (10 /zM). At 2 h, the 
cell suspensions were filtered on glassfiber filters (Whatman GF/A)  and washed with 4 × 3 ml of phosphate-buffered saline. The filters were air-dried and 
counted. The values indicated are means _+S.D. of quadruplicate determinations expressed as percent of control uptake. The P-values were obtained by 
Bonferroni's multiple comparison test comparing the test values against control. Parallel cultures indicated that the cell count and viability were not 
changed significantly by the presence of the inhibitors during the 2 h of incubation. The uptake of [3H]tamoxifen i the control wells amounted to 14.6% 
of the number of counts added at the beginning of the experiment. 
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treatment have been extensiively studied [1]. The fact that 
emetine had no protective effect against amoxifen-induced 
cell death in MCF7 cells (Fig. 5) but exhibited clear 
protection for K36 cells (Fig. 1) would suggest hat there 
are at least two different mechanisms by which non- 
steroidal antiestrogens kill cells; only one of these can be 
blocked by protein synthesiis inhibitors. It is possible that 
antiestrogens kill 'target' cells (those with estrogen recep- 
tors) in a different manner from non-target cells, such as 
K36 and EL4 cells, which do not contain estrogen recep- 
tors. This possibility remains to be explored further. 
We have examined the possibility that the metabolic 
inhibitors might interfere with the cellular uptake of antie- 
strogens, thereby reducing their apparent cytotoxic po- 
tency. Using the conditions described in Table 3, we were 
unable to show that any of the inhibitors reduced 
[3H]tamoxifen uptake. We have also considered an alterna- 
tive interpretation f our data: that the inhibition of protein 
synthesis reduces the energy requirement of the cells and 
thus prolongs their survival in the face of a limited energy 
supply provided by the culture medium. This possibility is 
plausible only when the culture medium is not changed for 
prolonged periods of time and seems unlikely under our 
experimental conditions where cell death was induced in 
about 48 h by the antiestrogens. It would seem, therefore, 
reasonable to suggest hat antiestrogen-induced ll death, 
at least in K36 or EL4 cells, is likely to involve mecha- 
nisms requiring protein synthesis. 
Nevertheless, we have some reservations about this 
interpretation. In the first place, although protective con- 
centrations of emetine, cycloheximide, puromycin and 
actinomycin D were also effective in inhibiting protein or 
RNA synthesis, the degree of inhibition of macromolecular 
synthesis was highly variable. In the case of puromycin, 
for example, a maximally protective concentration i hib- 
ited protein synthesis by only about 10%. It is difficult to 
visualize how a 10% reduction in protein synthesis could 
block the cytotoxicity of antiestrogens if indeed protein 
synthesis is an obligatory step in the mechanism of antie- 
strogen-induced cell death This could be the case only if 
the putative protein required to mediate cell death is 
rate-limiting, a point which cannot be tested directly at 
present. 
The non-steroidal ntie,;trogens are known to bind with 
high affinity not only to the estrogen receptor but also to a 
ubiquitously distributed microsomal protein, the antiestro- 
gen binding site (AEBS) which was identified as a distinct 
entity more than a decade ago [12]. Our laboratory has 
earlier shown that, among,, compounds which bind to the 
AEBS and which exhibit cytotoxic effects, the cytotoxic 
potency (as measured by the ECs0 values) broadly paral- 
leled their binding affinities for the AEBS [13]. On the 
basis of this observation, as well as the studies of other 
investigators [14,15], we :suggested that the AEBS might 
mediate the cytotoxic effects of its ligands. In particular, 
other classes of ligands of the AEBS, such as diphenyl- 
methane derivatives [14] and synthetic analogues of triph- 
enylethylene antiestrogens [15], have also been found to 
have cytotoxic potencies which parallel their binding 
affinities for the AEBS. Nevertheless, currently there is no 
direct evidence for the hypothesis that AEBS mediates the 
cytotoxicity of any of its ligands. It is possible that the 
AEBS may be one of the proteins involved antiestrogen-in- 
duced cell death and that the inhibition of its synthesis 
may partly explain the protective ffect of inhibitors of 
protein and RNA synthesis. Further studies are needed to 
examine this possibility. 
Finally, it should be emphasized that the studies de- 
scribed here demonstrate primarily an in vitro phe- 
nomenon, namely the dependence of antiestrogen-induced 
cell death on protein synthesis. Whether this in vitro 
biological phenomenon has any in vivo counterpart, for 
example in breast cancer patients treated with tamoxifen, is
not known. Indeed, the results obtained with MCF7 cells 
(Fig. 5) would suggest hat tamoxifen kills such 'target' 
cells via a different mechanism which is not  dependent on 
protein synthesis. Nevertheless, the studies with K36 and 
EL4 cells revealed an interesting biological phenomenon 
which suggests that at least one of the cytotoxic mecha- 
nisms of non-steroidal ntiestrogens appears to depend on 
de novo protein synthesis. This cytotoxic effect of antie- 
strogens on K36 or EL4 cells could provide a potentially 
useful model for the identification of proteins involved in 
the regulation of cell death and survival. 
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